| |
| |
|
| Insider
Information: |
Terrillion Scott |
| Relationship: |
|
| City: |
Stamford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
88,247 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$66,194 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
88,247 |
|
|
| Total
Value |
$66,194 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cara Therapeutics, Inc. |
CARA |
|
2024-04-05 |
88,247 |
2018-12-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
31 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2018-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,486 |
9,486 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2019-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
14,719 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2019-12-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
20,749 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
32,769 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2020-04-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,334 |
41,103 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2020-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
44,382 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2021-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
48,436 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
54,432 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
67,342 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2021-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,334 |
72,676 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2021-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
11,495 |
82,412 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
102,412 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,333 |
105,773 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
SECY; CHIEF COMPLIANCE & G.C. |
• – – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
102,063 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
SECY; CHIEF COMPLIANCE & G.C. |
• – – |
2024-04-05 |
4 |
AS |
$0.83 |
$2,285 |
D/D |
(2,753) |
88,247 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
SECY; CHIEF COMPLIANCE & G.C. |
• – – |
2024-02-29 |
4 |
AS |
$0.89 |
$2,931 |
D/D |
(3,293) |
91,000 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
SECY; CHIEF COMPLIANCE & G.C. |
• – – |
2023-02-08 |
4 |
AS |
$0.53 |
$4,118 |
D/D |
(7,770) |
94,293 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2023-06-23 |
4 |
AS |
$3.51 |
$8,715 |
D/D |
(2,483) |
88,563 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2023-04-04 |
4 |
AS |
$4.91 |
$12,182 |
D/D |
(2,481) |
91,046 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2022-04-01 |
4 |
AS |
$11.91 |
$19,556 |
D/D |
(1,642) |
102,344 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2022-02-25 |
4 |
AS |
$10.29 |
$20,292 |
D/D |
(1,972) |
100,440 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2022-03-03 |
4 |
AS |
$11.38 |
$20,336 |
D/D |
(1,787) |
103,986 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2021-08-30 |
4 |
AS |
$14.20 |
$24,978 |
D/D |
(1,759) |
70,917 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2020-12-30 |
4 |
AS |
$15.30 |
$29,774 |
D/D |
(1,946) |
42,436 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Secy; Chief Compliance & G.C. |
• – – |
2018-12-28 |
4 |
AS |
$12.51 |
$38,781 |
D/D |
(3,100) |
6,386 |
0 |
- |
|
31 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
